Skip to content

A randomized parallel controlled clinical study of acupuncture for the treatment of asthenospermia in obese men

A randomized parallel controlled clinical study of acupuncture for the treatment of asthenospermia in obese men

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002025
Enrollment
Unknown
Registered
2025-10-28
Start date
2025-10-31
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthenospermia combined with obesity

Interventions

Acupuncture group:Acupuncture
Sham acupuncture group:Non-meridian and non-acupuncture point shallow stab

Sponsors

Xiyuan Hospital Chinese Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
22 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) Meanwhile meet the diagnostic criteria for both asthenospermia and obesity; (2) 22 years old = age = 45 years old; (3) No fertility needs in the past six months; (4) Voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Congenital chromosomal abnormalities or microdeletions of the Y chromosome or other known hereditary diseases that may affect semen quality; (2) Combined with oligospermia or obstructive azoospermia; (3) Combined with moderate to severe varicocele cryptorchidism or orchitis or epididymitis or mycoplasma or chlamydia or other diseases that clearly affect semen quality; (4) Combined with diabetes mellitus requiring long-term medication to control blood glucose; (5) Combined with serious cardiovascular diseases or serious cerebrovascular diseases or hematopoietic system diseases or psychiatric diseases or other complications; (6) Receipt of other relevant treatments for this disease such as aromatase inhibitors or estrogen antagonists etc. two weeks prior to treatment; (7) Fear of needles or fainting during acupuncture treatment in the past.

Design outcomes

Primary

MeasureTime frame
percentage of progressive motility spermatozoa;

Secondary

MeasureTime frame
sperm concentration;percentage of progressive motility spermatozoa plus percentage of non-progressive motility spermatozoa;semen volume;body mass index;waist-to-hip ratio;body fat percentage;

Countries

China

Contacts

Public ContactGuo Jun

Xiyuan Hospital Chinese Academy of Chinese Medical Sciences

guojun1126@126.com13911272060

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Mar 13, 2026